Global companion animal vaccines market estimated to be valued US$ 2406 Mn in 2017 and poised to grow at CAGR of 7.8% over 2017-2023. Market for companion animal vaccines projected to reach US$ 3767 Mn by 2023 owing to rising human and companion animals bondage by means of adoption across the globe.

 

Global Companion Animal Vaccines Market Report Description:

• Companion animal vaccines market report gives comprehensive outlook on companion animal vaccines across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA).

• This report studies companion animal vaccines market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.

 

Global Companion Animal Vaccines Market:

• Increased awareness about pet health among pet owners projected to create market demand for companion animal vaccines over the forecast period

• Companion animals are primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal vaccines over the forecast period.

 

Increasing per pet expenditure in recent times expected to drive market revenue growth

• North America market leads the global companion animal vaccines market, According to data from American Pet Products association as of 2016, around 40% of households owned one or the other pet animals.

• Europe companion animal vaccines market holds significant share in global companion animal vaccines market.

 

Get Free Sample Research Report @ https://www.jsbmarketresearch.com/sample-request/global-companion-animal-vaccines-market

 

Competition Assessment

Key players profiles in the global companion animal vaccines market include:

• Bayer AG (Germany)

• Boehringer Ingelheim GmbH (Germany)

• Ceva Santé Animale (France)

• Eli Lilly and Company (U.S)

• Heska Co. (U.S)

• Hester biosciences (India)

• Merck & Co., Inc. (U.S)

• Vétoquinol S.A. (France)

• Virbac S.A. (France)

• Zoetis Inc. (U.S)

 

Key Features of the Report:

• Based on product type canine vaccine accounted for larger market revenue share in 2016 and projected gain larger market revenue share over the forecast period

• Veterinary clinics distribution channel is the prime source for companion vaccines across the globe and expected to remain attractive over the forecast period

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

• The report tracks recent innovations, key developments and startup’s details that are actively working in the market

 

The report provides detailed market segmentation based on following type:

By Product Type

By Disease Type

By Vaccine Type

Distribution Channel

Geography

 

To Know More Browse Full Report @ https://www.jsbmarketresearch.com/healthcare-medical/global-companion-animal-vaccines-market

 

About JSB Market Research -

JSB market research is one of the most significant databases of online market researches and intelligence reports and services. we specialize in providing market research reports for various industries. the online portal for marketing research deals with access to global market data and assists in providing expert.

 

For Further Information, Kindly Contact:

JSB Market Research

Phone: +917710006748

Website: www.jsbmarketresearch.com

Email: - enquiry@jsbmarketresearch.com